Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3 ‐ TACC3 Fusion and Recurrent Glioblastoma
出版年份 2020 全文链接
标题
Targeted Therapy with Anlotinib for a Patient with an Oncogenic
FGFR3
‐
TACC3
Fusion and Recurrent Glioblastoma
作者
关键词
-
出版物
ONCOLOGIST
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-09-19
DOI
10.1002/onco.13530
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases
- (2019) Leomar Y. Ballester et al. Acta Neuropathologica Communications
- Increasing incidence of central nervous system (CNS) tumors (2000–2012): findings from a population based registry in Gironde (France)
- (2018) Camille Pouchieu et al. BMC CANCER
- Anlotinib: First Global Approval
- (2018) Yahiya Y. Syed DRUGS
- The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
- (2018) Bill H. Diplas et al. Nature Communications
- Bevacizumab combined with chemotherapy vs single-agent therapy in recurrent glioblastoma: evidence from randomized controlled trials
- (2018) Zhouqing Chen et al. Cancer Management and Research
- Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
- (2016) Yongkun Sun et al. Journal of Hematology & Oncology
- A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
- (2016) Hideyuki Arita et al. Acta Neuropathologica Communications
- Genetic Classification of Gliomas: Refining Histopathology
- (2015) Michael B. Foote et al. CANCER CELL
- Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
- (2015) A. L. Di Stefano et al. CLINICAL CANCER RESEARCH
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- Identification of Recurrent FGFR3-TACC3 Fusion Oncogenes from Lung Adenocarcinoma
- (2014) M. Capelletti et al. CLINICAL CANCER RESEARCH
- Molecularly targeted therapies for recurrent glioblastoma: current and future targets
- (2014) Darryl Lau et al. Neurosurgical Focus
- What do we know about IDH1/2 mutations so far, and how do we use it?
- (2013) Craig Horbinski ACTA NEUROPATHOLOGICA
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started